translation agency

CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update
GLOBAL: Qlucore Corrals EU Funding for Hepatitis C Software
By Ryan McBride
September 18, 2013
FierceBiotechIT (09.16.2013)

The European Commission’s Seventh Framework Program will award $801,360 throughout three years to scientific software company Qlucore to develop algorithms for use in personalizing hepatitis C treatment. The company will work on mathematical and statistical algorithms for integrating information from genetic, proteomic, and clinical research data to provide clinicians with a mobile application that could be used at the point of care. Pharmaceutical companies currently are developing new hepatitis C drugs that would lead to more genetic and clinical variables to evaluate for patients and create a need for tools that could assist clinicians in prescribing custom treatments for each patient.